Top

Published in:

07-02-2023 | Vaccination | ORIGINAL PAPER

The patient perspective on vaccine uptake in adults with psoriasis and eczema

Authors: Megan H. Noe, Marjorie Archila, John S. Barbieri, Nathaniel Goldman, Christina G. Lopez, Arash Mostaghimi, Aaron M. Scherer, Alice J. Tan, Lourdes M. Perez-Chada, Maryam M. Asgari, Joel M. Gelfand

Published in: Archives of Dermatological Research | Issue 6/2023

Abstract

Having a chronic disease is one of the most consistent factors associated with vaccine uptake for adults in the general population, but vaccination beliefs and behaviors specific to those with chronic skin diseases have not been explored. The objective of this study was to explore factors associated with vaccine uptake and barriers to vaccination in adults with psoriasis and eczema. Virtual, video-based semi-structured interviews were performed with adults who self-reported a diagnosis of psoriasis or eczema. Interviews explored themes around healthcare decision making, perceived risks/benefits to vaccination, barriers, and vaccine knowledge. Thematic analysis was used to analyze the data. Of 34 study participants, 25 participants (74%) were females and 9 (26%) were males, with a mean age of 50.8 years (SD: 16.4, range: 24–71 yrs). Half of participants (n = 17) had psoriasis, and half (n = 17) had eczema. Participants recognized both personal and societal benefits to vaccines. Common vaccination barriers identified were access to appointments, concerns about side effects, and misinformation. Physicians, friends/family, and media, including internet resources, were health information resources identified by patients. These results summarize the unique patient perspective around vaccine uptake in adults with eczema and psoriasis and represent an important first step in a multi-pronged approach to improve vaccination rates in adults with chronic skin diseases.

Bechman K, Cook ES, Dand N, Yiu ZZN, Tsakok T, Meynell F, Coker B, Vincent A, Bachelez H, Barbosa I, Brown MA, Capon F, Contreras CR, De La Cruz C, Meglio PD, Gisondi P, Jullien D, Kelly J, Lambert J, Lancelot C, Langan SM, Mason KJ, McAteer H, Moorhead L, Naldi L, Norton S, Puig L, Spuls PI, Torres T, Urmston D, Vesty A, Warren RB, Waweru H, Weinman J, Griffiths CEM, Barker JN, Smith CH, Galloway JB, Mahil SK, PsoProtect study g, (2022) Vaccine hesitancy and access to psoriasis care during the COVID-19 pandemic: findings from a global patient-reported cross-sectional survey. Br J Dermatol 187(2):254–256. https://doi.org/10.1111/bjd.21042CrossRefPubMedPubMedCentral

Bloom DE, Cadarette D, Ferranna M (2021) The societal value of vaccination in the age of COVID-19. Am J Pub Health 111(6):1049–1054. https://doi.org/10.2105/AJPH.2020.306114CrossRef

Bonhomme A, Freling E, Reigneau M, Poreaux C, Valois A, Truchetet F, Barbaud A, Schmutz JL (2017) Vaccination status in psoriasis patients on immunosuppressant therapy (including biologics). Ann Dermatol Venereol 144(2):92–99. https://doi.org/10.1016/j.annder.2016.09.035CrossRefPubMed

Gelfand JM, Armstrong AW, Bell S, Anesi GL, Blauvelt A, Calabrese C, Dommasch ED, Feldman SR, Gladman D, Kircik L, Lebwohl M, Lo Re V, Martin G, Merola JF, Scher JU, Schwartzman S, Treat JR, Van Voorhees AS, Ellebrecht CT, Fenner J, Ocon A, Syed MN, Weinstein EJ, Smith J, Gondo G, Heydon S, Koons S, Ritchlin CT (2020) National psoriasis foundation COVID-19 task force guidance for management of psoriatic disease during the pandemic: Version 1. J Am Acad Dermatol 83(6):1704–1716. https://doi.org/10.1016/j.jaad.2020.09.001CrossRefPubMedPubMedCentral

Gondo GC, Noe MH, Bell SJ, Ritchlin CT (2021) Likelihood of COVID-19 vaccination among individuals living with psoriatic disease: results from a large real-world survey. J Psoriasis Psoriatic Arthritis 7(1):17–23. https://doi.org/10.1177/24755303211067822CrossRef

Harrison N, Poeppl W, Miksch M, Machold K, Kiener H, Aletaha D, Smolen JS, Forstner C, Burgmann H, Lagler H (2018) Predictors for influenza vaccine acceptance among patients with inflammatory rheumatic diseases. Vaccine 36(32):4875–4879. https://doi.org/10.1016/j.vaccine.2018.06.065CrossRefPubMed

Keddem S, Barg FK, Frasso R (2021) Practical guidance for studies using freelisting interviews. Prev Chronic Dis 18:E04. https://doi.org/10.5888/pcd17.200355CrossRefPubMedPubMedCentral

Krasselt M, Baerwald C, Seifert O (2017) Insufficient vaccination rates in patients with systemic lupus erythematosus in a German outpatient clinic. Z Rheumatol. https://doi.org/10.1007/s00393-017-0410-5CrossRef

Kromer C, Wellmann P, Siemer R, Klein S, Mohr J, Pinter A, Wilsmann-Theis D, Mossner R (2021) Influenza vaccination in psoriatic patients-epidemiology and patient perceptions: A German Multicenter Study (Vac-Pso). Vaccines (Basel) 9(8):843. https://doi.org/10.3390/vaccines9080843CrossRefPubMed

10.

Loomba S, de Figueiredo A, Piatek SJ, de Graaf K, Larson HJ (2021) Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA. Nat Hum Behav 5(3):337–348. https://doi.org/10.1038/s41562-021-01056-1CrossRefPubMed

11.

Noe MH, Shin DB, Hubbard RA, Hennessy S, Gelfand JM (2019) Influenza vaccination rates in adults with psoriasis compared to adults with other chronic diseases. J Invest Dermatol 139(2):473–475. https://doi.org/10.1016/j.jid.2018.09.012CrossRefPubMed

12.

Patel D, Maczuga S, Helm MF, Foulke GT (2021) A retrospective cohort study confirms that prophylactic vaccination is underused in patients on tumor necrosis factor inhibitors. J Am Acad Dermatol 84(4):1150–1152. https://doi.org/10.1016/j.jaad.2020.07.018CrossRefPubMed

13.

Pierri F, Perry BL, DeVerna MR, Yang K-C, Flammini A, Menczer F, Bryden J (2022) Online misinformation is linked to early COVID-19 vaccination hesitancy and refusal. Sci Rep 12(1):5966. https://doi.org/10.1038/s41598-022-10070-wCrossRefPubMedPubMedCentral

14.

Radtke MA, Rustenbach SJ, Reusch M, Stromer K, Augustin M (2013) Influenza vaccination rate among patients with moderate to severe psoriasis. J Dtsch Dermatol Ges 11(9):837–844. https://doi.org/10.1111/ddg.12010CrossRefPubMed

15.

Sbidian E, Tubach F, Pasquet B, Paul C, Jullien D, Sid-Mohand D, Bachelez H (2012) Factors associated with 2009 monovalent H1N1 vaccine coverage: a cross sectional study of 1,308 patients with psoriasis in France. Vaccine 30(39):5703–5707. https://doi.org/10.1016/j.vaccine.2012.07.014CrossRefPubMed

16.

Shen SC, Dubey V (2019) Addressing vaccine hesitancy: Clinical guidance for primary care physicians working with parents. Can Fam Phys 65(3):175–181

17.

Sotiriou E, Bakirtzi K, Papadimitriou I, Paschou E, Vakirlis E, Lallas A, Ioannides D (2021) COVID-19 vaccination intention among patients with psoriasis compared with immunosuppressed patients with other skin diseases and factors influencing their decision. Br J Dermatol 185(1):209–210. https://doi.org/10.1111/bjd.19882CrossRefPubMedPubMedCentral

18.

Taylor JA, Darden PM, Slora E, Hasemeier CM, Asmussen L, Wasserman R (1997) The influence of provider behavior, parental characteristics, and a public policy initiative on the immunization status of children followed by private pediatricians: a study from Pediatric Research in Office Settings. Pediatrics 99(2):209–215CrossRefPubMed

19.

Toh MP, Kannan P, Chen Y, Chng FL, Tang WE (2012) Healthcare workers and H1N1 vaccination: does having a chronic disease make a difference? Vaccine 30(6):1064–1070. https://doi.org/10.1016/j.vaccine.2011.12.037CrossRefPubMed

20.

Tong A, Sainsbury P, Craig J (2007) Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care 19(6):349–357. https://doi.org/10.1093/intqhc/mzm042CrossRefPubMed

21.

Yeung MP, Lam FL, Coker R (2016) Factors associated with the uptake of seasonal influenza vaccination in adults: a systematic review. J Public Health (Oxf) 38(4):746–753. https://doi.org/10.1093/pubmed/fdv194CrossRefPubMed

Title: The patient perspective on vaccine uptake in adults with psoriasis and eczema
Authors: Megan H. Noe
Marjorie Archila
John S. Barbieri
Nathaniel Goldman
Christina G. Lopez
Arash Mostaghimi
Aaron M. Scherer
Alice J. Tan
Lourdes M. Perez-Chada
Maryam M. Asgari
Joel M. Gelfand
Publication date: 07-02-2023
Publisher: Springer Berlin Heidelberg
Keywords: Vaccination
Vulgar Psoriasis
Published in: Archives of Dermatological Research / Issue 6/2023
Print ISSN: 0340-3696
Electronic ISSN: 1432-069X
DOI: https://doi.org/10.1007/s00403-023-02546-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The patient perspective on vaccine uptake in adults with psoriasis and eczema

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2023

Ethnoracial representation in hidradenitis suppurativa clinical trials

Intradermal injection of tranexamic acid versus platelet-rich plasma in the treatment of melasma: a split-face comparative study

SNHG1 functions as a ceRNA in hypertrophic scar fibroblast proliferation and apoptosis through miR-320b/CTNNB1 axis

Patients’ perspectives towards biologic dose reduction in psoriasis: a qualitative study

Anemia in patients with hidradenitis suppurativa

Perceptions and attitudes regarding HIV pre-exposure prophylaxis (PrEP) among dermatology clinicians and trainees